Cargando…

Mobile e‐diary application facilitates the monitoring of patient‐reported outcomes and a high treatment adherence for clinical trials in dermatology

BACKGROUND: Assessment of treatment effects in clinical trials requires valid information on treatment adherence, adverse events and symptoms. Paper‐based diaries are often inconvenient and have limited reliability, particularly for outpatient trials. OBJECTIVES: To investigate the utility of an ele...

Descripción completa

Detalles Bibliográficos
Autores principales: Rijsbergen, M., Niemeyer‐van der Kolk, T., Rijneveld, R., Pinckaers, J.H.F.M., Meshcheriakov, I., Bouwes Bavinck, J.N., van Doorn, M.B.A., Hogendoorn, G., Feiss, G., Cohen, A.F., Burggraaf, J., van Poelgeest, M.I.E., Rissmann, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064941/
https://www.ncbi.nlm.nih.gov/pubmed/31419338
http://dx.doi.org/10.1111/jdv.15872
_version_ 1783504964702699520
author Rijsbergen, M.
Niemeyer‐van der Kolk, T.
Rijneveld, R.
Pinckaers, J.H.F.M.
Meshcheriakov, I.
Bouwes Bavinck, J.N.
van Doorn, M.B.A.
Hogendoorn, G.
Feiss, G.
Cohen, A.F.
Burggraaf, J.
van Poelgeest, M.I.E.
Rissmann, R.
author_facet Rijsbergen, M.
Niemeyer‐van der Kolk, T.
Rijneveld, R.
Pinckaers, J.H.F.M.
Meshcheriakov, I.
Bouwes Bavinck, J.N.
van Doorn, M.B.A.
Hogendoorn, G.
Feiss, G.
Cohen, A.F.
Burggraaf, J.
van Poelgeest, M.I.E.
Rissmann, R.
author_sort Rijsbergen, M.
collection PubMed
description BACKGROUND: Assessment of treatment effects in clinical trials requires valid information on treatment adherence, adverse events and symptoms. Paper‐based diaries are often inconvenient and have limited reliability, particularly for outpatient trials. OBJECTIVES: To investigate the utility of an electronic diary (e‐diary) application for patients with skin diseases in outpatient clinical trials. METHODS: An e‐diary application was developed and technically validated. Treatment adherence was defined as topical administration by the patient, and patient‐reported outcomes, i.e. pain and itch, were evaluated by the e‐diary in six clinical trials on newly tested topical drugs. Additionally, the proportion of patients capturing the applied topical drug by camera and filling in the pain and itch scores was defined as e‐diary adherence, and patients’ perception of usefulness and acceptability of the e‐diary were evaluated. RESULTS: Treatment adherence rates of the included 256 patients were high (median 98%, range 97–99%). E‐diary adherence was also high with a median of 93% (range 87–97%) for capturing the applied drug by camera, and 89% (range 87–96%) and 94% (range 87–96%) for entering respectively the itch and pain score. Daily symptom scores provided good insights into the disease burden, and patients rated the e‐diary as good to excellent with respect to user acceptability. CONCLUSIONS: The results suggest that the e‐diary is an excellent way to ensure proper treatment administration, indicated by both the high user acceptability scores and high treatment adherence. Moreover, the e‐diary may also be valuable for frequent and reliable monitoring of patient‐reported outcomes in daily clinical practice.
format Online
Article
Text
id pubmed-7064941
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70649412020-03-16 Mobile e‐diary application facilitates the monitoring of patient‐reported outcomes and a high treatment adherence for clinical trials in dermatology Rijsbergen, M. Niemeyer‐van der Kolk, T. Rijneveld, R. Pinckaers, J.H.F.M. Meshcheriakov, I. Bouwes Bavinck, J.N. van Doorn, M.B.A. Hogendoorn, G. Feiss, G. Cohen, A.F. Burggraaf, J. van Poelgeest, M.I.E. Rissmann, R. J Eur Acad Dermatol Venereol Teledermatology BACKGROUND: Assessment of treatment effects in clinical trials requires valid information on treatment adherence, adverse events and symptoms. Paper‐based diaries are often inconvenient and have limited reliability, particularly for outpatient trials. OBJECTIVES: To investigate the utility of an electronic diary (e‐diary) application for patients with skin diseases in outpatient clinical trials. METHODS: An e‐diary application was developed and technically validated. Treatment adherence was defined as topical administration by the patient, and patient‐reported outcomes, i.e. pain and itch, were evaluated by the e‐diary in six clinical trials on newly tested topical drugs. Additionally, the proportion of patients capturing the applied topical drug by camera and filling in the pain and itch scores was defined as e‐diary adherence, and patients’ perception of usefulness and acceptability of the e‐diary were evaluated. RESULTS: Treatment adherence rates of the included 256 patients were high (median 98%, range 97–99%). E‐diary adherence was also high with a median of 93% (range 87–97%) for capturing the applied drug by camera, and 89% (range 87–96%) and 94% (range 87–96%) for entering respectively the itch and pain score. Daily symptom scores provided good insights into the disease burden, and patients rated the e‐diary as good to excellent with respect to user acceptability. CONCLUSIONS: The results suggest that the e‐diary is an excellent way to ensure proper treatment administration, indicated by both the high user acceptability scores and high treatment adherence. Moreover, the e‐diary may also be valuable for frequent and reliable monitoring of patient‐reported outcomes in daily clinical practice. John Wiley and Sons Inc. 2019-09-04 2020-03 /pmc/articles/PMC7064941/ /pubmed/31419338 http://dx.doi.org/10.1111/jdv.15872 Text en © 2019 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Teledermatology
Rijsbergen, M.
Niemeyer‐van der Kolk, T.
Rijneveld, R.
Pinckaers, J.H.F.M.
Meshcheriakov, I.
Bouwes Bavinck, J.N.
van Doorn, M.B.A.
Hogendoorn, G.
Feiss, G.
Cohen, A.F.
Burggraaf, J.
van Poelgeest, M.I.E.
Rissmann, R.
Mobile e‐diary application facilitates the monitoring of patient‐reported outcomes and a high treatment adherence for clinical trials in dermatology
title Mobile e‐diary application facilitates the monitoring of patient‐reported outcomes and a high treatment adherence for clinical trials in dermatology
title_full Mobile e‐diary application facilitates the monitoring of patient‐reported outcomes and a high treatment adherence for clinical trials in dermatology
title_fullStr Mobile e‐diary application facilitates the monitoring of patient‐reported outcomes and a high treatment adherence for clinical trials in dermatology
title_full_unstemmed Mobile e‐diary application facilitates the monitoring of patient‐reported outcomes and a high treatment adherence for clinical trials in dermatology
title_short Mobile e‐diary application facilitates the monitoring of patient‐reported outcomes and a high treatment adherence for clinical trials in dermatology
title_sort mobile e‐diary application facilitates the monitoring of patient‐reported outcomes and a high treatment adherence for clinical trials in dermatology
topic Teledermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064941/
https://www.ncbi.nlm.nih.gov/pubmed/31419338
http://dx.doi.org/10.1111/jdv.15872
work_keys_str_mv AT rijsbergenm mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology
AT niemeyervanderkolkt mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology
AT rijneveldr mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology
AT pinckaersjhfm mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology
AT meshcheriakovi mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology
AT bouwesbavinckjn mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology
AT vandoornmba mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology
AT hogendoorng mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology
AT feissg mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology
AT cohenaf mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology
AT burggraafj mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology
AT vanpoelgeestmie mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology
AT rissmannr mobileediaryapplicationfacilitatesthemonitoringofpatientreportedoutcomesandahightreatmentadherenceforclinicaltrialsindermatology